Informationen:
Fehler:
ID
13773
Beschreibung
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01459497
Link
https://clinicaltrials.gov/show/NCT01459497
Stichworte
Versionen (1)
- 06.03.16 06.03.16 -
Hochgeladen am
6. März 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Non-small Cell Lung Cancer NCT01459497
Eligibility Non-small Cell Lung Cancer NCT01459497
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Non-small Cell Lung Cancer NCT01459497
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
informed consent
Item
all patients must be willing and capable to provide informed consent to participate in the protocol.
boolean
C0021430 (UMLS CUI [1])
tumor stage non small cell lung cancer; biopsy; cytology
Item
patients must have appropriate staging studies identifying them as ajcc stage ii or iii non small cell lung cancer, (according to ajcc staging, 6th edition; see appendix iii), or recurrent non small cell lung cancer. histologic confirmation of cancer will be required by biopsy or cytology within 6 months of study entry.
boolean
C1300072 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C0005558 (UMLS CUI [2])
C0010819 (UMLS CUI [3])
C0007131 (UMLS CUI [1,2])
C0005558 (UMLS CUI [2])
C0010819 (UMLS CUI [3])
local therapy
Item
patients must have the potential for benefit from local therapy (at the discretion of the investigator).
boolean
C1517925 (UMLS CUI [1])
zubrod performance status
Item
the patient's zubrod performance status must be 2 or greater or patients with zubrod performance status 0-1 and weight loss >10% are considered eligible. in addition, patients determined to be medically unfit or refusing combined modality therapy are eligible.
boolean
C3714786 (UMLS CUI [1])
age
Item
age ≥ 18.
boolean
C0001779 (UMLS CUI [1])
Measurable Disease
Item
patients must have measurable or evaluable disease.
boolean
C1513041 (UMLS CUI [1])
Contraception status
Item
women of childbearing potential and male participants must agree to use an effective method of contraception.
boolean
C0420837 (UMLS CUI [1])
informed consent
Item
patients must sign study specific informed consent prior to study entry.
boolean
C0021430 (UMLS CUI [1])
concurrent therapy
Item
patients must not have plans for concurrent chemoradiation therapy.
boolean
C0009429 (UMLS CUI [1])
treatment evaluation
Item
patients must complete all required pretreatment evaluations
boolean
C0557980 (UMLS CUI [1])
tumor volume
Item
total (aggregate) gross tumor volume > 500 cm3 (500 cc's or 0.5 liters)
boolean
C0475276 (UMLS CUI [1])
radiotherapy
Item
prior radiotherapy to the region of the study cancer that would result in direct overlap of radiation therapy fields.
boolean
C1522449 (UMLS CUI [1])
chemotherapy
Item
chemotherapy given within one week of study registration.
boolean
C0392920 (UMLS CUI [1])
pregnancy; lactating
Item
pregnant or lactating women, as treatment involves unforeseeable risks to the embryo or fetus.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])